Cytopenias in Hospitalized Patients of Corona Virus Infection(COVID-19) During First and Other Waves

Sponsor
Fatima Memorial Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05258812
Collaborator
(none)
202
1
14
14.5

Study Details

Study Description

Brief Summary

Demographic, Clinical and laboratory data as well as outcome of total 202 COVID-19 patients who were Polymerase Chain Reaction (PCR) positive and admitted in Fatima memorial Hospital, Lahore, Pakistan, was collected during first and other waves. Data of First wave is from May 2020 to July 2020, second wave from early November to Mid December 2020 and third wave from Mid march to June 2021. Investigator analyzed the data on basis of Systemic immune inflammatory index (SII) as well hematological parameters of First Wave were compared to other waves of COVID-19.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    202 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Cytopenias in Hospitalized Patients of COVID-19 During First and Other Waves
    Actual Study Start Date :
    May 1, 2020
    Actual Primary Completion Date :
    Jun 30, 2021
    Actual Study Completion Date :
    Jun 30, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Cytopenias in Hospitalized Patients of COVID-19 During First and Other waves [4 weeks]

      extent of cytopenias is being measured in COVID-19 hospitalized patients.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years to 95 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • COVID-19 Positive Hospitalized patients

    • All genders

    Exclusion Criteria:
    • Patients with Known hematological disorders

    • Patients with known chronic Liver Disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fatima memorial Hospital Lahore Punjab Pakistan 54000

    Sponsors and Collaborators

    • Fatima Memorial Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Ambreen Kashif, Doctor, Fatima Memorial Hospital
    ClinicalTrials.gov Identifier:
    NCT05258812
    Other Study ID Numbers:
    • FMH
    First Posted:
    Feb 28, 2022
    Last Update Posted:
    Feb 28, 2022
    Last Verified:
    Feb 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ambreen Kashif, Doctor, Fatima Memorial Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 28, 2022